Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Edesa Biotech (EDSA) Gross Margin (2016 - 2020)

Edesa Biotech's Gross Margin history spans 8 years, with the latest figure at 362.8% for Q3 2020.

  • For Q3 2020, Gross Margin changed N/A year-over-year to 362.8%; the TTM value through Jun 2021 reached 362.8%, down 45815.0%, while the annual FY2020 figure was 94.65%, N/A changed from the prior year.
  • Gross Margin for Q3 2020 was 362.8% at Edesa Biotech, down from 98.66% in the prior quarter.
  • Across five years, Gross Margin topped out at 163.91% in Q3 2016 and bottomed at 1873.89% in Q3 2017.
  • The 5-year median for Gross Margin is 67.39% (2016), against an average of 155.48%.
  • The largest annual shift saw Gross Margin crashed -544849bps in 2016 before it skyrocketed 202392bps in 2018.
  • A 5-year view of Gross Margin shows it stood at 44.62% in 2016, then tumbled by -949bps to 378.6% in 2017, then surged by 140bps to 150.03% in 2018, then crashed by -36bps to 96.5% in 2019, then crashed by -476bps to 362.8% in 2020.
  • Per Business Quant, the three most recent readings for EDSA's Gross Margin are 362.8% (Q3 2020), 98.66% (Q2 2020), and 90.92% (Q1 2020).